|
1
|
Nava F, Tramacere I, Fittipaldo A,
Bruzzone MG, Dimeco F, Fariselli L, Finocchiaro G, Pollo B,
Salmaggi A, Silvani A, et al: Survival effect of first- and
second-line treatments for patients with primary glioblastoma: A
cohort study from a prospective registry, 1997–2010. Neuro Oncol.
16:719–727. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang JB, Dong DF, Gao K and Wang MD:
Mechanisms underlying the biological changes induced by isocitrate
dehydrogenase-1 mutation in glioma cells. Oncol Lett. 7:651–657.
2014.PubMed/NCBI
|
|
3
|
Zhou Y, Xu Y, Wang H, Niu J, Hou H and
Jiang Y: Histone deacetylase inhibitor, valproic acid,
radiosensitizes the C6 glioma cell line in vitro. Oncol Lett.
7:203–208. 2014.PubMed/NCBI
|
|
4
|
Shen SH, Kwan AL, Chen YY and Wang ZX:
Effect of silencing HIF-1α on proliferation, invasion and migration
of glioblastoma U87 cells. Neurol Sci. 34:365–371. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu JH, Yao YL, Gu T, Wang ZY, Pu XY, Sun
WW, Zhang X, Jiang YB and Wang JJ: MiR-421 regulates apoptosis of
BGC-823 gastric cancer cells by targeting caspase-3. Asian Pac J
Cancer Prev. 15:5463–5468. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lagos-Quintana M, Rauhut R, Lendeckel W
and Tuschl T: Identification of novel genes coding for small
expressed RNAs. Science. 294:853–858. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang TS, Yang XH, Wang XD, Wang YL, Zhou B
and Song ZS: MiR-214 regulate gastric cancer cell proliferation,
migration and invasion by targeting PTEN. Cancer Cell Int.
13:682013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu D, Pan H, Zhou Y, Zhou J, Fan Y and Qu
P: microRNA-133b downregulation and inhibition of cell
proliferation, migration and invasion by targeting matrix
metallopeptidase-9 in renal cell carcinoma. Mol Med Rep.
9:2491–2498. 2014.PubMed/NCBI
|
|
10
|
Sun L, Yan W, Wang Y, Sun G, Luo H, Zhang
J, Wang X, You Y, Yang Z and Liu N: MicroRNA-10b induces glioma
cell invasion by modulating MMP-14 and uPAR expression via HOXD10.
Brain Res. 1389:9–18. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhao H, Li M, Li L, Yang X, Lan G and
Zhang Y: MiR-133b is down-regulated in human osteosarcoma and
inhibits osteosarcoma cells proliferation, migration and invasion
and promotes apoptosis. PLoS One. 8:e835712013 View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wen D, Li S, Ji F, Cao H, Jiang W, Zhu J
and Fang X: MiR-133b acts as a tumor suppressor and negatively
regulates FGFR1 in gastric cancer. Tumour Biol. 34:793–803. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nohata N, Hanazawa T, Enokida H and Seki
N: MicroRNA-1/133a and microRNA-206/133b clusters: Dysregulation
and functional roles in human cancers. Oncotarget. 3:9–21. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Landgraf P, Rusu M, Sheridan R, Sewer A,
Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M,
et al: A mammalian microRNA expression atlas based on small RNA
library sequencing. Cell. 129:1401–1414. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Karatas OF, Guzel E, Suer I, Ekici ID,
Caskurlu T, Creighton CJ, Ittmann M and Ozen M: MiR-1 and miR-133b
are differentially expressed in patients with recurrent prostate
cancer. PLoS One. 9:e986752014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu L, Shao X, Gao W, Zhang Z, Liu P, Wang
R, Huang P, Yin Y and Shu Y: MicroRNA-133b inhibits the growth of
non-small-cell lung cancer by targeting the epidermal growth factor
receptor. FEBS J. 279:3800–3812. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kano M, Seki N, Kikkawa N, Fujimura L,
Hoshino I, Akutsu Y, Chiyomaru T, Enokida H, Nakagawa M and
Matsubara H: MiR-145, miR-133a and miR-133b: Tumor-suppressive
miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J
Cancer. 127:2804–2814. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Duan FT, Qian F, Fang K, Lin KY, Wang WT
and Chen YQ: MiR-133b, a muscle-specific microRNA, is a novel
prognostic marker that participates in the progression of human
colorectal cancer via regulation of CXCR4 expression. Mol Cancer.
12:1642013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Al-Raawi D, Abu-El-Zahab H, El-Shinawi M
and Mohamed MM: Membrane type-1 matrix metalloproteinase (MT1-MMP)
correlates with the expression and activation of matrix
metalloproteinase-2 (MMP-2) in inflammatory breast cancer. Int J
Clin Exp Med. 4:265–275. 2011.PubMed/NCBI
|
|
20
|
Arroyo AG, Genís L, Gonzalo P,
Matí-as-Román S, Pollán A and Gálvez BG: Matrix metalloproteinases:
New routes to the use of MT1-MMP as a therapeutic target in
angiogenesis-related disease. Curr Pharm Des. 13:1787–1802. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Basile JR, Holmbeck K, Bugge TH and
Gutkind JS: MT1-MMP controls tumor-induced angiogenesis through the
release of semaphorin 4D. J Biol Chem. 282:6899–6905. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Albrechtsen R, Kveiborg M, Stautz D,
Vikeså J, Noer JB, Kotzsh A, Nielsen FC, Wewer UM and Fröhlich C:
ADAM12 redistributes and activates MMP-14, resulting in gelatin
degradation, reduced apoptosis and increased tumor growth. J Cell
Sci. 126:4707–4720. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang L, Yuan J, Tu Y, Mao X, He S, Fu G,
Zong J and Zhang Y: Co-expression of MMP-14 and MMP-19 predicts
poor survival in human glioma. Clin Transl Oncol. 15:139–145. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xie H, Xue YX, Liu LB, Wang P, Liu YH and
Ying HQ: Expressions of matrix metalloproteinase-7 and matrix
metalloproteinase-14 associated with the activation of
extracellular signal-regulated kinase1/2 in human brain gliomas of
different pathological grades. Med Oncol. (28 Suppl 1): S433–S438.
2011. View Article : Google Scholar : PubMed/NCBI
|
